Understanding barriers to preferred contraceptive methods in low-resource areas
Official title: Non-Preferred Contraceptive Method Use in Low-Resourced Settings: Exploring Inappropriate Medical Contraindications and Person-Centered Care
Funded at Univ of North Carolina Chapel Hill · NIH-10903358 · Data updated 2026-11-12
This study is looking into the unnecessary hurdles women encounter when trying to get the birth control they want, especially in places with fewer resources, and aims to make it easier for them to access their preferred options so they can feel happier with their family planning choices.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project start | August 18, 2024 |
| Project end | August 17, 2026 |
| Funding year | 2024 |
| Award (this year) | $37,329 |
| NIH project number | 1F31HD113329-01A1 |
| Project ID | NIH-10903358 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are women living in low-resource settings who are seeking contraceptive care and may have faced barriers to accessing their preferred methods.
✕Less likely to help
Patients who are not seeking contraceptive care or who live in high-resource settings may not benefit from this research.
What this research studies
This research investigates the unnecessary medical barriers that women face when trying to access their preferred contraceptive methods in low-resource settings. It focuses on identifying inappropriate medical contraindications (IMCs) that prevent eligible women from receiving the contraceptives they want, often without a valid medical reason. By employing social accountability interventions, the study aims to reduce the use of non-preferred contraceptive methods and improve overall satisfaction with family planning services. The research will gather data on the frequency and nature of these barriers to inform better practices in contraceptive care.
Why it matters
Potential benefit: If successful, this research could lead to improved access to preferred contraceptive methods for women in low-resource settings, ultimately reducing unwanted pregnancies and enhancing maternal and child health.
How similar studies have gone: Previous research has indicated that addressing medical barriers to contraceptive access can lead to significant improvements in family planning outcomes, suggesting that this approach has potential for success.
Where this research is happening
-
Univ of North Carolina Chapel Hill
Chapel Hill, United States Active
Researchers
- Principal investigator: Chung, Stephanie Roslyn-Isabelle — Univ of North Carolina Chapel Hill
- Study coordinator: Chung, Stephanie Roslyn-Isabelle
Related research
Other NIH-funded projects on the same topics.
-
A center for coordinating data related to heart and blood health.
This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.
-
Healthy work design and worker well-being
A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.
-
Unified and fair multimodal learning for autoimmune diseases
A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.
-
Structural factors linking minimum wage, COVID-19, and community violence
A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
How HPV interacts with our cells' DNA damage system and its effect on cancer
This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.